Analgesic and Anti-inflammatory Potential of Hygrophila Spinosa and Curcuma Longa: An Updated review

The body uses inflammation as a defence mechanism against viruses, tissue damage, and toxic substances. On the other hand, chronic inflammation has a role in the development of cancer, diabetes, neurological illnesses, cardiovascular disease, and arthritis. One of the most frequent reasons for seeking medical attention is pain, which is intimately linked to inflammatory processes.

NSAIDs and corticosteroids are examples of conventional anti-inflammatory drugs that are helpful but can have negative side effects such gastrointestinal ulcers, nephrotoxicity, and cardiovascular problems. As a result, medicinal plants with enhanced safety profiles and anti-inflammatory and analgesic qualities are gaining popularity.

Hygrophila spinosa and Curcuma longa are two traditional medicinal plants that have garnered a lot of interest because of their widespread ethnomedical use and pharmacological properties that have been verified by science. Their phytoconstituents include immunomodulatory, anti-inflammatory, antioxidant, and antinociceptive qualities, indicating possible therapeutic uses in inflammatory conditions.

2. METHODOLOGY OF LITERATURE SEARCH

The literature was collected from:

• PubMed
• Scopus
• Web of Science
• Google Scholar
• ScienceDirect

Publications from 2000–2025 were reviewed with emphasis on peer-reviewed research articles, review papers, and pharmacological studies.

3. BOTANICAL PROFILE OF HYGROPHILA SPINOSA

TAXONOMY

TRADITIONAL USES

• Rheumatism
• Joint pain
• Inflammation
• Urinary disorders
• Hepatic disorders
• Edema
• General debility

The plant contains flavonoids, alkaloids, sterols, terpenoids, tannins, and phenolic compounds contributing to its medicinal properties

MAJOR PHYTOCHEMICAL CLASSES

• Alkaloids
• Flavonoids
• Steroids
• Triterpenoids
• Saponins
• Tannins
• Glycosides
• Phenolic compounds

 

 

FIGURE 1. BOTANICAL REPRESENTATION OF HYGROPHILA SPINOSA

 

 

PATHOPHYSIOLOGY OF PAIN AND INFLAMMATION AND THE ROLE OF HYGROPHILA SPINOSA

After tissue damage, infection, or exposure to damaging stimuli, pain and inflammation are closely associated physiological reactions. Redness, swelling, heat, pain, and loss of function are signs of inflammation. Inflammatory mediators like histamine, serotonin, bradykinin, prostaglandins, leukotrienes, and pro-inflammatory cytokines like tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) are released when immune cells like neutrophils, mast cells, and macrophages are activated.

These mediators encourage leukocyte migration to the site of damage by increasing vascular permeability. Concurrently, prostaglandins produced by the cyclooxygenase (COX) pathway cause nociceptors to become more sensitive, which causes pain perception. By continuously activating peripheral and central sensitization processes, persistent inflammation can result in chronic pain.

Numerous bioactive phytochemicals, such as flavonoids, alkaloids, sterols, triterpenoids, tannins, and phenolic compounds, are present in Hygrophila Spinosa. Through a variety of processes, these components support its analgesic and anti-inflammatory properties. By scavenging reactive oxygen species (ROS) and lowering oxidative stress, which is a significant factor in inflammatory tissue damage, flavonoids and phenolic compounds function as powerful antioxidants.

Experimental studies suggest that extracts of H. spinosa inhibit the synthesis and release of inflammatory mediators such as prostaglandins and cytokines. The plant may suppress the activation of nuclear factor-kappa B (NF-κB), a key transcription factor involved in the expression of inflammatory genes. Inhibition of NF-κB leads to reduced production of TNF-α, IL-1β, and IL-6, thereby attenuating the inflammatory response.

The analgesic effect of H. spinosa is attributed to its ability to interfere with peripheral pain pathways by reducing prostaglandin formation and inflammatory mediator release. Additionally, certain phytoconstituents may exert central analgesic effects by modulating neurotransmitter systems involved in pain transmission. Reduction of oxidative stress and inflammatory cytokine production further contributes to pain relief.

Overall, the anti-inflammatory and analgesic properties of Hygrophila spinosa are mediated through antioxidant activity, inhibition of inflammatory mediator synthesis, suppression of pro-inflammatory cytokines, stabilization of cellular membranes, and modulation of pain signaling pathways. These pharmacological actions support its traditional use in the management of inflammatory disorders and painful conditions.

4. BOTANICAL PROFILE OF CURCUMA LONGA

TAXONOMY

TRADITIONAL USES

• Arthritis
• Wound healing
• Pain management
• Inflammatory diseases
• Gastrointestinal disorders

The rhizome is rich in curcuminoids and volatile oils responsible for therapeutic activity. Another important factor in the pathophysiology of inflammation is oxidative stress. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) produced by activated immune cells during inflammation result in lipid peroxidation, cellular damage, and a

FIGURE 2. BOTANICAL REPRESENTATION OF CURCUMA LONGA:

5. PHYTOCHEMISTRY OF HYGROPHILA SPINOSA

Major phytoconstituents include:

FLAVONOIDS

• Apigenin
• Luteolin
• Quercetin derivatives

TRITERPENOIDS

• Lupeol
• Betulin
• Lupenone

STEROLS

• β-Sitosterol
• Stigmasterol

ALKALOIDS

• Asteracanthine
• Asteracanthicine

OTHER CONSTITUENTS

• Tannins
• Phenolics
• Fatty acids
• Glycosides

These compounds exhibit antioxidant, anti-inflammatory, and analgesic effects.

6. PHYTOCHEMISTRY OF CURCUMA LONGA

CURCUMINOIDS

• Curcumin
• Demethoxycurcumin
• Bisdemethoxycurcumin

ESSENTIAL OILS

• Turmerone
• Atlantone
• Zingiberene

OTHER CONSTITUENTS

• Proteins
• Polysaccharides
• Phenolic compounds

Curcumin is considered the principal bioactive compound responsible for anti-inflammatory and analgesic actions.

PATHOPHYSIOLOGY OF PAIN AND INFLAMMATION AND THE ROLE OF CURCUMA LONGA

Inflammation and pain are defensive physiological reactions brought on by immune-mediated harm, infection, or tissue damage. When immune cells like neutrophils, macrophages, and mast cells are activated during acute inflammation, they release inflammatory mediators such histamine, serotonin, bradykinin, prostaglandins, leukotrienes, and cytokines. These mediators cause pain, redness, swelling, and heat by increasing vascular permeability, encouraging leukocyte infiltration, and stimulating nociceptors.

The transcription factor Nuclear Factor Kappa B, which controls the production of pro-inflammatory genes encoding cytokines like TNF-α, IL-1β, IL-6, cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS), is activated during inflammation. Persistent pain and chronic inflammatory disorders are linked to the overproduction of these mediators.

n increase in inflammatory signaling pathways. Pain receptor sensitization and tissue damage are encouraged by prolonged oxidative stress.

Curcumin is the main pharmacologically active polyphenol found in Curcuma longa, or turmeric. Through a variety of molecular pathways, curcumin demonstrates strong analgesic and anti-inflammatory properties. It decreases the transcription of inflammatory cytokines, chemokines, COX-2, and iNOS via suppressing NF-κB activation. As a result, prostaglandins, nitric oxide, TNF-α, IL-1β, and IL-6 are produced at much lower levels.

Additionally, curcumin reduces the production of prostaglandins and leukotrienes, which influence pain and inflammation, by inhibiting the activity of the enzymes cyclooxygenase and lipoxygenase. Curcumin also has potent antioxidant qualities, scavenging free radicals and boosting natural antioxidant defenses including glutathione peroxidase, catalase, and superoxide dismutase (SOD).Curcuma longa's analgesic effects are mainly ascribed to its regulation of pain-signaling pathways and suppression of inflammatory mediator production. By lowering prostaglandin synthesis, curcumin lessens peripheral sensitivity. It may also affect central pain pathways by modifying neurotransmitters and inflammatory signals in the central nervous system.

Recent studies further indicate that curcumin regulates multiple intracellular signaling cascades, including the mitogen-activated protein kinase (MAPK) pathway, Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway, and Toll-like receptor (TLR)-mediated inflammatory responses. Through these mechanisms, Curcuma longa effectively suppresses both acute and chronic inflammatory processes.

7. ANALGESIC ACTIVITY OF HYGROPHILA SPINOSA

Experimental studies have demonstrated significant analgesic activity using:

• Hot plate test
• Tail flick test
• Acetic acid-induced writhing test

Extracts of alcohol and chloroform dramatically decreased pain reactions, indicating both peripheral and central analgesic processes. Flavonoids, sterols, and triterpenoids that affect prostaglandin synthesis and nociceptive pathways may be responsible for the reported action.

8. ANTI-INFLAMMATORY ACTIVITY OF HYGROPHILA SPINOSA

Studies using carrageenan-induced paw edema models demonstrated significant inhibition of inflammation by alcoholic and chloroform extracts.

Proposed mechanisms include:

• Inhibition of prostaglandin synthesis
• Reduction of inflammatory mediators

These findings support the traditional use of the plant in rheumatism and inflammatory disorders.

9. ANALGESIC ACTIVITY OF CURCUMA LONGA

Curcuma longa exhibits potent antinociceptive activity in:

• Formalin test
• Acetic acid writhing test
• Tail immersion test

Curcumin reduces pain perception by modulating:

• Substance P
• TRPV1 receptors
• Cyclooxygenase pathways
• Nitric oxide production

Experimental studies suggest efficacy comparable to standard analgesics in some models.

10. ANTI-INFLAMMATORY ACTIVITY OF CURCUMA LONGA

Curcumin exerts anti-inflammatory effects through multiple pathways:

SUPPRESSION OF PRO-INFLAMMATORY CYTOKINES

• TNF-α
• IL-1β
• IL-6

INHIBITION OF ENZYMES

• COX-2
• LOX
• iNOS

MODULATION OF SIGNALING PATHWAYS

• NF-κB
• MAPK
• JAK/STAT

These mechanisms contribute to the reduction of edema, inflammatory cell infiltration, and oxidative damage.

11. COMPARATIVE PHARMACOLOGICAL PROFILE

13. TOXICOLOGICAL ASSESSMENT

H. spinosa extracts have comparatively low toxicity at therapeutic dosages, according to acute toxicity tests. The experimental animals did not exhibit any notable behavioral problems or death.

But there are still a few restrictions:

• Studies on chronic toxicity are lacking.

• Limited assessment of reproductive toxicity

• Inadequate information on human safety

• The lack of uniform dosage recommendations

Prior to clinical application, additional toxicological research is necessary.

14. FUTURE PERSPECTIVES

Future research should focus on:

1. Isolation of active constituents.
2. Standardization of extracts.
3. Pharmacokinetic studies.
4. Toxicological evaluation.
5. Clinical trials.
6. Nanoformulation development.
7. Evaluation of synergistic combinations.

CONCLUSION

According to available data, the various phytochemical components of Hygrophila Spinosa and Curcuma longa may have important analgesic and anti-inflammatory effects. Their traditional application in pain and inflammatory conditions is supported by experimental research. In contrast to Hygrophila spinosa, which has promising pharmacological potential but is still understudied, Curcuma longa has considerably stronger clinical data. For the treatment of chronic inflammatory disorders and pain syndromes, combined formulations may offer a novel therapeutic approach. To determine efficacy, safety, and standardization for therapeutic usage, more clinical research is needed.

REFERENCES

1. Indian Materia Medica. Nadkarni AK. Indian Materia Medica. Mumbai: Popular Prakashan; 2007.
2. Kshirsagar AD, Ingale KG, Vyawahare NS, Thorve VS. Hygrophila spinosa: A comprehensive review. Pharmacognosy Reviews. 2010;4(8):167–171.
3. Gaikwad S, Kothapalli L, Thomas A. Phytochemical and Pharmacological Aspects of Hygrophila Spinosa: An Overview. Current Traditional Medicine. 2023.
4. Patra A, Jha S, Murthy PN. Phytochemical and Pharmacological Potential of Hygrophila spinosa T. Anders. Pharmacognosy Reviews. 2009.
5. Kumar V, Abbas AK, et al. Ethnomedicinal, phytochemical and pharmacological updates on Hygrophila auriculata. Journal of Integrative Medicine. 2018.
6. Ahmed S, Rahman M, Islam M. Anti-inflammatory activity of Hygrophila auriculata extracts in experimental animal models.
7. Singh A, Malhotra S. Analgesic activity of Hygrophila spinosa leaf extracts using hot plate and writhing tests.
8. Rao KN, et al. Evaluation of anti-inflammatory potential of Asteracantha longifolia in carrageenan-induced paw edema.
9. Shanmugasundaram P, Venkataraman S. Hepatoprotective and antioxidant activities of Hygrophila auriculata.
10. Fuloria S, Mehta J, Chandel A, et al. A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin. Frontiers in Pharmacology. 2022.
11. Rahaman MM, Rakib A, Mitra S, et al. The Genus Curcuma and Inflammation: Overview of the Pharmacological Perspectives. Plants. 2021;10(1):63.
12. Amalraj A, Pius A, Gopi S, Gopi S. Biological activities of curcuminoids and turmeric. Journal of Traditional and Complementary Medicine. 2017.
13. Hewlings SJ, Kalman DS. Curcumin: A Review of Its Effects on Human Health. Foods. 2017.
14. Gupta SC, Patchva S, Aggarwal BB. Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials. AAPS Journal. 2013.
15. Aggarwal BB, Harikumar KB. Potential Therapeutic Effects of Curcumin. International Journal of Biochemistry & Cell Biology. 2009.
16. Menon VP, Sudheer AR. Antioxidant and Anti-inflammatory Properties of Curcumin. Advances in Experimental Medicine and Biology. 2007.
17. Joe B, Vijaykumar M, Lokesh BR. Biological Properties of Curcumin. Critical Reviews in Food Science and Nutrition. 2004.
18. Chainani-Wu N. Safety and Anti-inflammatory Activity of Curcumin. Alternative Medicine Review. 2003.
19. Jurenka JS. Anti-inflammatory Properties of Curcumin. Alternative Medicine Review. 2009.
20.  Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”: From Kitchen to Clinic. Biochemical Pharmacology. 2008.